Furthermore, studies targeting CXCR3 in murine models of breast and melanoma observed inhibitory effects were specifically against tumor metastasis while the primary tumor mass was unaffected (49–51), indicating that CXCR3 has a role in promoting metastasis but not incidence. This evidence concerns the gene CXCR3 and melanoma.